[Low HDL-cholesterol, high triglycerides--well known but often ignored].
A reduced HDL-Cholersterol and increased triglyzerides are an often seen laboratory abnormality. They are known risk factors for arteriosclerosis. However the small influence of a pharamcologic treatment on the two reduced the interest in them. We therefore want to show the relation of the triglyzerides with the HDL-Cholesterol and the nonpharmacologic treatment of these two factors. Some clinical examples are illustrating the topic.
Benz
R
R
Medizinische Poliklinik, Hypertonie- und Adipositassprechstunde, Universitätsspital Zürich. rudolf.benz@usz.ch
Suter
P M
PM
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology; D000069059:Atorvastatin; D008076:Cholesterol, HDL / Q000097:blood*; D002995:Clofibric Acid / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015444:Exercise; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis; D009525:Niacin / Q000627:therapeutic use; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D016540:Smoking Cessation; D014280:Triglycerides / Q000097:blood*; D015431:Weight Loss; D014944:World Health Organization
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011758:Pyrroles; D014280:Triglycerides; D009525:Niacin; D002995:Clofibric Acid; D000069059:Atorvastatin